أعرض في EDS

Supplemental Figure S1 and Table S1 from A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers

التفاصيل البيبلوغرافية
العنوان: Supplemental Figure S1 and Table S1 from A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers
المؤلفون: Glenwood D. Goss, Mark DeMario, Ka Wang, David Geho, Tiantom Jarutat, Suzana M. Vega-Harring, Markus Roessler, Hua Zhong, Dean Bottino, Kathleen J. Schostack, Mary E. Simcox, Aaron R. Hansen, Derek J. Jonker, Jan H.M. Schellens, Morten Mau-Sorensen, Vaios Karanikas, Lilian L. Siu, Didier Meulendijks, Ulrik N. Lassen
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplemental Figure S1 and Table S1. Figure S1: RG7212 phase I study flow diagram and treatment schema. Table S1. Summary of Fn14 Testing and Positivity Rate (IHC{greater than or equal to}1+) for the Most Commonly Screened Solid Tumors
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0ab408c3772903e1549f808a8c8771
https://doi.org/10.1158/1078-0432.22460889.v1
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....3e0ab408c3772903e1549f808a8c8771
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.